A graduate of Wellesley College, Harvard University and Boston University, Dr. Yap has trained with Suzanne Flynn, PhD, in the Department of Foreign Languages & Literature Department at the Massachusetts Institute of Technology, Gil G. Noam, PhD, EdD, Dipl. Phil., at the Laboratory of Developmental Psychology & Developmental Psychopathology at the Hall-Mercer Center for Children & Adolescents at the McLean Hospital, and Michael W. Otto, PhD, at the Clinical Psychopharmacology & Behavior Therapy Unit in the Department of Psychiatry at the Massachusetts General Hospital. She has served as a mentor to students selected for the American Federation for Aging Research (AFAR) Medical Student Geriatrics Scholars Program, and is honored to be selected as a mentor to one of the 26 talented students chosen as the MGH's Bicentennial Scholars . As part of Dr. Yap's commitment to support innovative research and treatments for Alzheimer's disease, she is also an annual reviewer for grant propoals submitted to the Alzheimer's Association for competitive funding.
Dr. Yap was elected in 2012 to serve a 3-year term on the national Alzheimer's Disease Centers' (ADCs) Administrators Steering Committee. As an administrator, she is always keen on developing reciprocal exchange programs between institutions to provide access to different research and teaching environments and technologies.
A project that Dr. Yap had developed was the creation of a brand-new website in 2010 for the Center, together with web-developers from Agaric Design Collective  and Stephane Corlosquet  of the Science Collaboration Framework , and led by Tim Clark  of the Data Core. She is quite thrilled with the results.
My passion is in academic administration. I also have a keen interest in outreach to underserved communities with regard to neurodegenerative diseases, and supporting foreign medical students and post-doc researchers in their training & productivity during their time with us in Boston.
Gould, RA, Buckminster, S, Pollack, MH, Otto, MW, Yap, L. Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis. Clin Psychol Sci Pract 1997; 4: 291-306.
Locascio JL, Fukumoto H, Yap, L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC. Plasma Amyloid Beta Protein and C-Reactive Protein in Relation to Rate of Progression of Alzheimer Disease. Arch Neurol 2008; 65: 776-785. [PMCID: 2662621].
Farabaugh A, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert J, Growdon J, Fava M. Depressive Symptom Patterns in Parkinson's Disease. Psychosomatics 2009; 50: 448-454.
Rudolph JL, Zanin NM, Jones RN, Marcantonio ER, Fong TG, Yang FM, Yap L, Inouye Sk. Hospitalization in Community-Dwelling Persons with Alzheimer's Disease: Frequency and Causes. J Am Geriatr Soc 2010; 58: 1542-1548. [PMCID: 2955171].
Farabaugh, AH, Locascio JJ, Yap, L, Fava M, Bitran S, Sousa JL, Growdon JH. Assessing Depression and Factors Possibly Associated with Depression During the Course of Parkinson's Disease. Annals Clin Psychiatry 2011; 23: 171-177. [PMCID: 3164778].
More publications may be found at www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed